Free Trial

Price T Rowe Associates Inc. MD Raises Holdings in Northrop Grumman Co. (NYSE:NOC)

Northrop Grumman logo with Aerospace background

Price T Rowe Associates Inc. MD raised its stake in shares of Northrop Grumman Co. (NYSE:NOC - Free Report) by 28.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,030,644 shares of the aerospace company's stock after acquiring an additional 450,858 shares during the period. Price T Rowe Associates Inc. MD owned approximately 1.40% of Northrop Grumman worth $952,962,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Whipplewood Advisors LLC purchased a new stake in shares of Northrop Grumman during the fourth quarter worth approximately $31,000. Albion Financial Group UT purchased a new position in Northrop Grumman during the 4th quarter worth $33,000. Modus Advisors LLC acquired a new stake in shares of Northrop Grumman in the 4th quarter worth $38,000. Stonebridge Financial Group LLC purchased a new stake in shares of Northrop Grumman in the fourth quarter valued at about $42,000. Finally, Rakuten Securities Inc. increased its stake in shares of Northrop Grumman by 291.7% during the fourth quarter. Rakuten Securities Inc. now owns 94 shares of the aerospace company's stock worth $44,000 after acquiring an additional 70 shares during the period. 83.40% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, VP Benjamin R. Davies sold 192 shares of Northrop Grumman stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $429.08, for a total value of $82,383.36. Following the completion of the sale, the vice president now owns 709 shares of the company's stock, valued at $304,217.72. The trade was a 21.31 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kathy J. Warden sold 3,750 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $475.65, for a total value of $1,783,687.50. Following the transaction, the chief executive officer now owns 212,852 shares in the company, valued at $101,243,053.80. This trade represents a 1.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 4,505 shares of company stock worth $2,127,182. 0.23% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Truist Financial lowered their price objective on Northrop Grumman from $600.00 to $550.00 and set a "buy" rating on the stock in a report on Wednesday. Royal Bank of Canada decreased their price target on Northrop Grumman from $575.00 to $550.00 and set an "outperform" rating on the stock in a research note on Wednesday. Barclays dropped their price objective on Northrop Grumman from $550.00 to $500.00 and set an "equal weight" rating on the stock in a report on Monday, January 6th. Morgan Stanley raised their target price on Northrop Grumman from $580.00 to $625.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Finally, UBS Group lowered their price target on shares of Northrop Grumman from $583.00 to $571.00 and set a "buy" rating on the stock in a research note on Wednesday. Ten investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Northrop Grumman currently has a consensus rating of "Moderate Buy" and an average price target of $542.94.

View Our Latest Analysis on Northrop Grumman

Northrop Grumman Price Performance

NYSE:NOC traded up $10.31 during trading hours on Friday, reaching $473.38. 1,329,267 shares of the company traded hands, compared to its average volume of 885,333. Northrop Grumman Co. has a 1-year low of $418.60 and a 1-year high of $555.57. The stock has a market cap of $68.13 billion, a P/E ratio of 16.70, a P/E/G ratio of 3.73 and a beta of 0.20. The firm's 50-day moving average is $491.64 and its 200-day moving average is $489.95. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.01 and a quick ratio of 0.91.

Northrop Grumman (NYSE:NOC - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The aerospace company reported $6.06 EPS for the quarter, missing analysts' consensus estimates of $6.33 by ($0.27). The company had revenue of $9.47 billion for the quarter, compared to analysts' expectations of $10.07 billion. Northrop Grumman had a return on equity of 26.24% and a net margin of 10.17%. Equities research analysts expect that Northrop Grumman Co. will post 28.05 earnings per share for the current fiscal year.

Northrop Grumman Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 19th. Investors of record on Monday, March 3rd were paid a dividend of $2.06 per share. This represents a $8.24 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Monday, March 3rd. Northrop Grumman's payout ratio is 32.52%.

Northrop Grumman Company Profile

(Free Report)

Northrop Grumman Corporation operates as an aerospace and defense technology company in the United States, Asia/Pacific, Europe, and internationally. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-off and landing tactical ISR systems; and strategic long-range strike aircraft, tactical fighter and air dominance aircraft, and airborne battle management and command and control systems.

See Also

Institutional Ownership by Quarter for Northrop Grumman (NYSE:NOC)

Should You Invest $1,000 in Northrop Grumman Right Now?

Before you consider Northrop Grumman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northrop Grumman wasn't on the list.

While Northrop Grumman currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines